ClearPoint Neuro CLPT EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from ClearPoint Neuro’s reported figures.
Based on trailing twelve months.
The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about ClearPoint Neuro's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ClearPoint Neuro's EBITDA margin?
- ClearPoint Neuro (CLPT) reported EBITDA margin of -63.2% in Q1 2026.
- How has ClearPoint Neuro's EBITDA margin changed year-over-year?
- ClearPoint Neuro's EBITDA margin increased by 2.2% year-over-year, from -64.7% to -63.2%.
- What is the long-term trend for ClearPoint Neuro's EBITDA margin?
- Over 5 years (2020 to 2025), ClearPoint Neuro's EBITDA margin has grown at a 6.6% compound annual growth rate (CAGR), from -45.9% to -63.2%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.